COVID-19 Impact on Respiratory Devices in Healthcare Industry | DBMR

Posted by swarajya on April 21st, 2021

COVID-19 Impact on Respiratory Devices in Healthcare Industry

The coronavirus pandemic has made an unbelievable effect on global economy system and as well as on daily lives of human beings. The impact on the healthcare sector has been adversely affected too and a huge burden is developed on already pinched healthcare sectors across the globe. Continuous research on coronavirus shows that the COVID-19 pandemic has elevated the psychological distress in both general population and among high risk population.

In July 2020, it became obvious that the novel strain of coronavirus or COVID-19 has major impact on the healthcare system in the United States. The Surgeon General, American College of Surgeons and Centers for Medicare and Medicaid Services have stated the issue of delaying or cancelling of non-essential medical and surgical services to decrease the exposure risk of the virus and conserve resources for expected number of infected population.

Moreover, during the pandemic phase, the people suffering from respiratory diseases are at higher risk since coronavirus majorly affects or damage the respiratory system and decreases the oxygen demand of the body. Due to this, the respiratory devices industry gained importance and growing with the fastest growth rate. As the number of COVID-19 patients’ increases, the demand of respiratory devices also increased.

For instance,

According to the Global Data Estimation, approximately 880,000 ventilators are required globally to fight with this pandemic and provide proper treatment facilities to the patients. The respiratory devices market turns out to be life saving for those who need mechanical support to the breathing cycle. Hence, the global respiratory devices market demand is positively impacted by the COVID-19 pandemic.

The impact of COVID-19 on respiratory devices market has been described by some pointers such as impact on supply chain, impact on price, impact on demand, impact on healthcare economy, strategic initiatives taken by pharmaceutical industries and government and their conclusion.

IMPACT ON DEMAND

The COVID-19 global pandemic has highlighted the complex interdependencies which exist within the global healthcare sector. The coronavirus disease (COVID-19) pandemic outbreak has created huge demand for respiratory devices such as ventilators, anaesthetic machines and others in the healthcare sector across the world. As day-by-day, the pandemic increases, the demand of the respiratory support devices also increases.

For instance,

• According to the Lancet Regional health USA, the demand of the ventilators was significantly increased or boost up at the peak time of pandemic
• According to studies published by STAT, between 5% to 11% in the U.S. hospitalizations have required intensive care and ventilators to survive with the help of artificial and mechanical breathing support. To support this, GE Healthcare and Ford made collaboration for manufacturing of ventilators for COVID-19 patients. They have announced to work together to scale up the manufacturing due to high demand of ventilators for treating the patients with COVID-19, the respiratory illness caused by the new coronavirus

IMPACT ON SUPPLY CHAIN

The coronavirus pandemic positivity impacted the respiratory devices market due to the increased demand of ventilators and anesthesia delivery devices as the coronavirus directly affects the respiratory system, which causes breathing problem and damage the lungs, which also boost the respiratory devices market. Even in normal days or situation where governments are attempting universal access to ventilators, the supply of these systems has constant opportunities due to usage factors. The sudden outbreak of COVID-19 and its sub-sequent high demand of ventilators to save the lives of human beings ramps up the supply chain of ventilators to meet the necessary demand across the world. Read more…